Exelixis, Inc. (EXEL) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Exelixis, Inc. (EXEL)

EXEL 42.15

-0.5%

11:19 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (158)	6/13/2005 5:12:28 AM
From: nigel bates	Read Replies (1) of 930

...Exelixis intends to consolidate the financial results of Symphony Evolution into its financial statements... If all three compounds crash & burn, they apparently walk away from the losses; if all three look good and they elect to buy them back, they end up paying around 2x what Symphony put into them... I can't quite see how consolidating the results reflects reality - though you have to give them credit for avoiding the 'off-balance-sheet' stigma. Be interesting to see the detail in the next 10K.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next